| Drug Type Therapeutic vaccine | 
| Synonyms | 
| Target | 
| Action inhibitors, stimulants | 
| Mechanism HBcrAg inhibitors(HBcrAg inhibitors), L-HBsAg inhibitors(L-HBsAg inhibitors), Immunostimulants | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| RegulationBreakthrough Therapy (China) | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 2 | China  | 30 May 2023 | 





